Sarah Chapin Columbia > McDermott Will & Emery LLP > Boston, United States > Lawyer Profile

Douglas Carsten leads McDermott Will & Emery LLP’s life sciences industry group from Orange County. The ‘quality’ team exhibits ‘industry knowledge and innovative thinking‘ as it advises private equity and venture capital firms investing in life sciences on financings and deals, as well as digital health and technology companies seeking assistance regarding FDA and regulatory issues. Pollard primarily dispenses regulatory and corporate advice to medical device and biotech companies on matters concerning clinical research, post-market safety and compliance with FDA regulated products, and manufacturing. The ‘masterful‘ Carsten is a ‘tremendous litigator‘ who acts in lucrative patent and Hatch-Waxman cases. Working out of the Boston office, Sarah Chapin Columbia focuses on IP and patent litigation, while Michael Siekman assists with the development and defense of biotech patent portfolios and acquisitions. William Gaede supports the team from Silicon Valley with his experience in life science technology IP litigations concerning small molecules, proteins, and diagnostics. Counsel Anisa Mohanty, based in Washington DC, has extensive expertise in pre-market FDA strategy and post-market compliance, often advising medical product manufacturers and biotech companies. Vernessa Pollard departed the team to join DLA Piper LLP (US) in February 2024.